Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?

Published:2016-09 Issue: Volume:105 Page:112-117
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Nazha Aziz^ORCID,Khoury Joseph D.,Verstovsek Srdan,Daver Naval

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference71 articles.

1. Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients;Alvarez-Larran;Br. J. Haematol.,2009

2. Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response: resistance, and intolerance to hydroxyurea in polycythemia vera;Alvarez-Larran;Blood,2012

3. Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. Leukemia and Hematosarcoma Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.);Br. J. Cancer,1981

4. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia;Anon;Ann. Intern. Med.,1995

5. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet;Barbui;J. Clin. Oncol.,2011

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera;Istanbul Medical Journal;2023-05-31

2. Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera;Hematology;2023-03

3. MDM2 antagonist idasanutlin in patients with polycythemia vera: results from a single-arm phase 2 study;Blood Advances;2021-12-21

4. Synthesis and characterization of bacterial cellulose-based composites for drug delivery;Carbohydrate Polymers;2021-12

5. Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera);Case Reports in Oncology;2021-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3